Michael A.S. Jewett

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

Naomi B. Haas, Judith Manola, Robert G. Uzzo et al. · The Lancet · 2016 · 638 citations

Medicine, Oncology, Pharmacology +14

The natural history of incidentally detected small renal masses

Alessandro Volpe, Tony Panzarella, Ricardo Rendon et al. · Cancer · 2004 · 525 citations · Full text

Medicine, Oncology, Radiology +17

Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer

Michael A.S. Jewett, Kamal Mattar, Joan Basiuk et al. · European Urology · 2011 · 497 citations

Medicine, Nephrology, Oncology +17

Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib

Axel Bex, Peter F.A. Mulders, Michael A.S. Jewett et al. · JAMA Oncology · 2018 · 490 citations · Full text

Medicine, Oncology, Surgery +17

Outcomes of Small Renal Mass Needle Core Biopsy, Nondiagnostic Percutaneous Biopsy, and the Role of Repeat Biopsy

Michael Leveridge, Antonio Finelli, John R. Kachura et al. · European Urology · 2011 · 404 citations

Medicine, Nephrology, Pathology +12